News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
9,674 Results
Type
Article (271)
Company Profile (1)
Press Release (9402)
Section
Business (2973)
Career Advice (11)
Deals (672)
Drug Development (608)
Employer Resources (2)
FDA (433)
Job Trends (372)
News (4830)
Policy (396)
Tag
2026 BioMidwest Elite (1)
2026 Biotech Bay Elite (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (1)
2026 Pharm Country Elite (1)
Academia (20)
Alliances (512)
Alzheimer's disease (5)
Antibody-drug conjugate (ADC) (1)
Approvals (442)
Artificial intelligence (2)
Bankruptcy (5)
Best Places to Work (373)
Biosimilars (1)
Breast cancer (2)
Cancer (19)
Career advice (10)
CAR-T (1)
Cell therapy (2)
Clinical research (569)
Collaboration (16)
Compensation (7)
COVID-19 (4)
C-suite (2)
Data (23)
Diabetes (1)
Diagnostics (16)
Drug discovery (3)
Drug pricing (1)
Earnings (1469)
Editorial (1)
Employer branding (2)
Employer resources (2)
Events (1525)
Executive appointments (9)
FDA (455)
Featured Employer (1)
Funding (3)
Gene therapy (1)
GLP-1 (2)
Government (26)
Guidances (2)
Healthcare (434)
IgA nephropathy (1)
Indications (1)
Infectious disease (4)
Inflammatory bowel disease (2)
Intellectual property (2)
IPO (327)
Job creations (38)
Job search strategy (9)
Layoffs (2)
Legal (108)
Liver cancer (2)
Lung cancer (2)
Lymphoma (3)
Manufacturing (2)
Medical device (393)
Medtech (393)
Mergers & acquisitions (360)
Metabolic disorders (6)
Multiple sclerosis (2)
Neuropsychiatric disorders (1)
Neuroscience (12)
NextGen: Class of 2025 (132)
Non-profit (20)
Northern California (13)
Obesity (4)
Opinion (2)
Ovarian cancer (3)
Pain (1)
Parkinson's disease (4)
Partnered (1)
Patents (4)
People (844)
Pharmaceutical (1)
Phase I (88)
Phase II (224)
Phase III (283)
Pipeline (22)
Postmarket research (23)
Preclinical (24)
Prostate cancer (2)
Radiopharmaceuticals (4)
Real estate (65)
Recruiting (1)
Regulatory (286)
Research institute (13)
Resumes & cover letters (2)
RNA editing (1)
Schizophrenia (3)
Series A (1)
Series B (1)
Southern California (44)
Startups (38)
Tariffs (2)
United States (261)
Vaccines (3)
Venture capitalists (1)
Weight loss (2)
Date
Today (4)
Last 7 days (12)
Last 30 days (36)
Last 365 days (458)
2025 (148)
2024 (504)
2023 (556)
2022 (930)
2021 (883)
2020 (873)
2019 (817)
2018 (571)
2017 (512)
2016 (464)
2015 (562)
2014 (353)
2013 (332)
2012 (389)
2011 (367)
2010 (244)
Location
Africa (4)
Arizona (3)
Asia (815)
Australia (175)
California (65)
Canada (50)
China (12)
Connecticut (3)
Delaware (2)
Europe (954)
Florida (9)
Idaho (2)
Illinois (59)
Japan (2)
Maryland (7)
Massachusetts (11)
Michigan (1)
Minnesota (5)
Missouri (1)
Nevada (1)
New Jersey (6)
New York (31)
North Carolina (5)
Northern California (13)
Pennsylvania (39)
Rhode Island (1)
South America (11)
South Carolina (1)
Southern California (44)
Tennessee (10)
Texas (7)
Washington D.C. (1)
Wisconsin (1)
9,674 Results for "eclipse aesthetics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Earnings
AbbVie’s Marketing Misstep Further Erodes 2024 Aesthetics Sales
AbbVie launched a revamped version of its Allē loyalty program, which ultimately was not adopted by providers. The marketing misstep comes as the company’s aesthetics franchise faces broader pressures.
February 3, 2025
·
4 min read
·
Annalee Armstrong
Press Releases
Vir Biotechnology Enrolls First Patient in Phase 3 ECLIPSE Registrational Program for Chronic Hepatitis Delta
March 13, 2025
·
9 min read
Pharm Country
Nikon introduces the SI-PH Phase Condenser accessory option for the ECLIPSE Si biological microscope
Nikon Instruments Inc. (Nikon) has developed the SI-PH Phase Condenser, for dedicated use with the ECLIPSE Si biological microscope, improving the efficiency of the ECLIPSE SI.
May 28, 2024
·
5 min read
Press Releases
Allergan Aesthetics Emphasizes Commitment to Innovation, Science and a Patient Centric Approach at AMWC 2025
March 24, 2025
·
10 min read
Press Releases
Crown Laboratories Announces Appointment of Adelle Walker as Chief Marketing Officer, Aesthetics
February 27, 2025
·
3 min read
Press Releases
AMWC 2025: Galderma Pushes the Innovation Frontier With Updates From Its Unparalleled Portfolio Designed to Meet the Needs of the Aesthetic Community
March 20, 2025
·
16 min read
Press Releases
Caliway’s CBL-514 Phase 2 Study (CBL-0202) Accepted for Publication in the Aesthetic Surgery Journal
March 12, 2025
·
6 min read
Deals
CROWN LABORATORIES EXPANDS AESTHETICS’ PORTFOLIO WITH ACQUISITION OF ECLIPSE MEDCORP, LLC ASSETS
Crown Laboratories (“Crown”), a leading, fully integrated global skincare company, has finalized an agreement with Eclipse, a medical technology company, to acquire its global, aesthetics-focused assets.
May 24, 2022
·
2 min read
Business
Allergan Aesthetics and University Lab Partners Announce the Golden Ticket Pitch Competition to Accelerate Aesthetics Start-Ups
University Lab Partners (ULP) is thrilled to announce the return of the Golden Ticket pitch competition for aesthetic startups, proudly sponsored by Allergan Aesthetics, an AbbVie Company.
April 12, 2024
·
2 min read
Drug Development
Curium Completes Patient Enrollment of Phase 3 ECLIPSE Trial Ahead of Schedule
Curium, a global leader in nuclear medicine, announced the successful completion of patient enrollment in the pivotal Phase 3 ECLIPSE trial.
November 23, 2023
·
2 min read
1 of 968
Next
